Marker Therapeutics, Inc. — Form D
Marker Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-24. The offering totals $3.1M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-24
- Form: D
- Accession: 0001144204-18-030789
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.1M
- Amount sold: $3.1M
- Investors: 1
- Date of first sale: 2018-05-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-313217
Issuer
- Name: Marker Therapeutics, Inc.
- CIK: 0001094038
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
- Phone: 713-400-6400
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Sherry Grisewood | Director | JACKSONVILLE, FL |
| Peter Hoang | Director | Houston, TX |
| David Laskow-Pooley | Director | JACKSONVILLE, FL |
| Mark Reddish | Director | JACKSONVILLE, FL |
| Frederick Wasserman | Director | Poughkeepsie, NY |
| Glynn Wilson | Director | Ponte Vedra, FL |
| Peter Hoang | Executive Officer | Houston, TX |
| Michael Loiacono | Executive Officer | JACKSONVILLE, FL |
| Joshua Silverman | Director | NEW YORK, NY |
| John Wilson | Director | Frisco, TX |
| Juan Vera | Director | Houston, TX |
| Juan Vera | Executive Officer | Houston, TX |
| Steven Elms | Director | Houston, TX |
| Katharine Knobil | Director | Sacramento, CA |
| David Eansor | Director | Houston, TX |
| Glynn Wilson | Executive Officer | Ponte Vedra, FL |
| John Bonfiglio | Director | TAMPA, FL |
| John Bonfiglio | Executive Officer | TAMPA, FL |
| Denis Corin | Director | Grand Cayman, E9 |
| Denis Corin | Executive Officer | Grand Cayman, E9 |
| MICHAEL J LOIACONO | Executive Officer | JACKSONVILLE, FL |
| TRACY MOORE | Director | VANCOUVER, A1 |
| TRACY MOORE | Executive Officer | VANCOUVER, A1 |
Other filings by this issuer (9)
More